drugset / Trial / NCT01280305
Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the study is to evaluate the efficacy of raloxifene compared to placebo, as add-on to anti-psychotics in the treatment of post menopausal patients with schizophrenia.
Timeline
- Start
- 2011-03
- Primary completion
- 2012-12
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Raloxifene | Other / unclassified | 60 mg | — |